Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..

The Centers for Disease Control and Prevention recommends N95 respirators for all providers who see patients with possible or confirmed coronavirus disease 2019 (COVID-19). We suggest that N95 respirators may be just as important for the care of patients without suspected COVID-19 when community incidence rates are high. This is because severe acute respiratory syndrome coronavirus 2 is most contagious before symptom onset. Ironically, by the time patients are sick enough to be admitted to the hospital with COVID-19, they tend to be less contagious. The greatest threat of transmission in healthcare facilities may therefore be patients and healthcare workers with early occult infection. N95 respirators' superior fit and filtration provide superior exposure protection for healthcare providers seeing patients with early undiagnosed infection and superior source control to protect patients from healthcare workers with early undiagnosed infection. The probability of occult infection in patients and healthcare workers is greatest when community incidence rates are high. Universal use of N95 respirators may help decrease nosocomial transmission at such times.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:74

Enthalten in:

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 74(2022), 3 vom: 11. Feb., Seite 529-531

Sprache:

Englisch

Beteiligte Personen:

Klompas, Michael [VerfasserIn]
Rhee, Chanu [VerfasserIn]
Baker, Meghan A [VerfasserIn]

Links:

Volltext

Themen:

Hospital infection control
Journal Article
N95 respirators
SARS-CoV-2 transmission

Anmerkungen:

Date Completed 16.02.2022

Date Revised 03.04.2024

published: Print

Citation Status MEDLINE

doi:

10.1093/cid/ciab539

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32661933X